Clinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes
Se Hee Min (Min SH), Soo Heon Kwak (Kwak SH), Young Min Cho (Cho YM), Kyong Soo Park (Park KS), Hye Seung Jung (Jung HS)
Endocrinol Metab. 2015;30(4):509-513.   Published online 2015 Dec 31     DOI: https://doi.org/10.3803/EnM.2015.30.4.509
Citations to this article as recorded by Crossref logo
Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study
Ji-Yeon Lee, Suk-Yong Jang, Chung Mo Nam, Eun Seok Kang
Scientific Reports.2019;[Epub]     CrossRef
A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
Eugene Han, Hye Sun Park, Obin Kwon, Eun Yeong Choe, Hye Jin Wang, Yong-ho Lee, Sang-Hak Lee, Chul Hoon Kim, Lee-Kyung Kim, Soo Heon Kwak, Kyong Soo Park, Chul Sik Kim, Eun Seok Kang
Medicine.2016; 95(44): e5155.     CrossRef